Ingrid Kreimerman
Radiopharmacy R&D
Montevideo, MO, Uruguay
Montevideo, MO, Uruguay
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer's disease.
Journal: Bioorganic & medicinal chemistry
Published: July 24, 2020
[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations.
Journal: Current radiopharmaceuticals
Published: November 20, 2018
Biological Assessment of a 18F-Labeled Sulforhodamine 101 in a Mouse Model of Alzheimer's Disease as a Potential Astrocytosis Marker.
Journal: Frontiers in neuroscience
Published: September 24, 2018
Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level.
Journal: Current radiopharmaceuticals
Published: June 29, 2018
Comparative In Vitro Study of 11C-Methionine and 11C-Deuterodeprenyl Uptake in Three Human Glioma Cell Lines.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: November 16, 2017
Synthesis of [18F]2B-SRF101: A Sulfonamide Derivative of the Fluorescent Dye Sulforhodamine 101.
Journal: Current radiopharmaceuticals
Published: July 07, 2017
An efficient preparation of labelling precursor of [11C]L-deprenyl-D2 and automated radiosynthesis.
Journal: EJNMMI radiopharmacy and chemistry
Published: January 01, 2017
Automated radiosynthesis of [(11)C]L-deprenyl-D2 and [(11)C]D-deprenyl using a commercial platform.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
Published: September 02, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026